Insider Trading & Ownership - Lavelle Erin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lavelle Erin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-04-25
Sale
2019-04-25
6:49 pm
ALDER BIOPHARMACEUTICALS INCALDRLavelle Erin
Chief Operating Officer
1,434$13.67$19,5994,408
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-08
Option Award
2023-06-09
4:25 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXLavelle Erin
Director
25,000$025,000
(Direct)
View
2022-10-31
Option Award
2022-11-02
7:08 pm
N/A
2032-10-30
Eliem Therapeutics Inc.ELYMLavelle Erin
COO & CFO
170,000$0170,000
(Direct)
View
2022-05-12
Option Award
2022-05-16
6:23 pm
N/A
2032-05-11
Neoleukin Therapeutics Inc.NLTXLavelle Erin
Director
25,000$025,000
(Direct)
View
2022-01-27
Option Award
2022-01-31
5:16 pm
N/A
2032-01-26
Eliem Therapeutics Inc.ELYMLavelle Erin
COO & CFO
170,000$0170,000
(Direct)
View

Ownership
2021-08-09
6:11 pm
N/A
2031-02-25
Eliem Therapeutics Inc.ELYMLavelle Erin
COO & CFO
0$0357,138
(Direct)
View
2019-10-22
Option Award
2019-10-24
7:12 pm
N/A
N/A
ALDER BIOPHARMACEUTICALS INCALDRLavelle Erin
Chief Operating Officer
11,684$00
(Direct)
View
2019-10-22
Equity Swap
2019-10-24
7:12 pm
N/A
N/A
ALDER BIOPHARMACEUTICALS INCALDRLavelle Erin
Chief Operating Officer
16,092$180
(Direct)
View
2019-10-22
Disposition
2019-10-24
7:12 pm
N/A
2028-04-15
ALDER BIOPHARMACEUTICALS INCALDRLavelle Erin
Chief Operating Officer
450,000$00
(Direct)
View
2019-04-23
Option Award
2019-04-25
6:49 pm
N/A
N/A
ALDER BIOPHARMACEUTICALS INCALDRLavelle Erin
Chief Operating Officer
5,842$04,408
(Direct)
View